Martin Zarba

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Martin Zarba

Dec 9, 2024, 19:14 | Insight

Efficacy of Treatments After Lenvatinib in Patients with Advanced Renal Cell Carcinoma

Toni Choueiri shared a post on X: "Efficacy of Treatments After Lenvatinib in Patients with…

Aug 19, 2024, 12:16 | Insight

Talal El Zarif: After adjuvant immunotherapy, what comes next in renal cell carcinoma?

Talal El Zarif shared a post by Karl Semaan, Postdoctoral Oncology Research Fellow at Dana-Farber…

Aug 16, 2024, 14:16 | Insight

Karl Semaan: First-line systemic therapy following adjuvant immunotherapy in renal cell carcinoma

Karl Semaan, Postdoctoral Research Fellow at Dana-Farber Cancer Institute, shared a post on X: “Just…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023